Answers are grounded in this paper and cite their sources.
Cyclophosphamide (CTX) is an alkylating chemotherapeutic agent that is often used as a first-line agent for treating hematological tumors in preadolescent females. However, CTX is known to cause damage to oocytes, which is worthy of further investigation. Human amniotic mesenchymal stem cells (hAMSCs) have antioxidant and anti-apoptotic properties, and the human amniotic mesenchymal stem cell-derived extracellular vesicles (hAMSC-EVs) secreted by hAMSCs may play an antioxidant function in the CTX-induced oxidative stress of oocytes and have the potential to preserve the quality of oocytes. Prepubertal female C57BL/6J mice (aged 3–6 weeks) were intraperitoneally injected with CTX, whereas the control group was injected intraperitoneally with the same dose of normal saline. The cumulus oocyte complexes (COCs) were removed from the mice after sexual maturity for in vitro maturation and fertilization, and the effects of CTX on the quality of oocytes were observed. COCs retrieved from preadolescent mice were subjected to in vitro culture supplemented with 4-hydroxycyclophosphamide (4-HC), an intermediate product after CTX, to mimic chemotherapeutic stress. Subsequently, the cytoprotective effects of hAMSC-EVs on these injured oocytes were evaluated. CTX directly injected into the abdominal cavity decreased the number of mouse oocytes obtained by promoting ovulation, decreasing the mitochondrial membrane potential of in vitro mature oocytes ( p < 0.05), and increasing the reactive oxygen species content ( p < 0.05). Additionally, 1 μM 4-HC decreased the mitochondrial membrane potential ( p < 0.05), increased the intracellular superoxide anion content ( p < 0.05), and decreased cytoplasmic maturity ( p < 0.05). The cleavage rate showed a decreasing trend but without statistical significance after cyclophosphamide treatment ( p = 0.1741), but the blastocyst formation rates of oocytes decreased significantly ( p < 0.05). hAMSC-EVs recovered intracellular oxidative stress injury induced by intraperitoneal injection of CTX and 1 μM 4-HC in vitro, and improved the subsequent blastocyst formation rate ( p < 0.05). hAMSC-EVs can down-regulate the overexpression of KLF4, P53, and P21 in the cells in vitro caused by intraperitoneal injection of CTX and 1 μM 4-HC ( p < 0.05). CTX and its metabolite 4-HC can reduce the quality of oocytes and impair their developmental potential, whereas hAMSC-EVs preserve the quality of oocytes and the developmental potential of subsequent embryos.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: